William H Smith1, Anish B Parikh2, Lihua Li3, Mark Sanderson4, Mark Liu5, Madhu Mazumdar3, Luis M Isola5, Kavita V Dharmarajan1,6. 1. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2. Division of Medical Oncology, The Ohio State University College of Medicine, Columbus, OH, USA. 3. Institute of Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 4. Department of Health System Design and Global Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6. Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
PURPOSE/ OBJECTIVES: We sought to estimate the expected cost savings generated if a set of potentially avoidable hospitalizations (PAHs) among oncology care model (OCM) patients with prostate cancer were shifted to an acute care model in the outpatient setting. METHODS: We previously identified a set of 28 PAHs among OCM prostate cancer patients. Outpatient management costs for a characteristically similar cohort of cancer patients were obtained from our institution's ambulatory acute-care Oncology Care Unit (OCU). We excluded OCU visits resulting in hospitalization, involving non-cancer diagnoses, and those missing clinical/financial information. Exact-matching based on the strata of age, categorically-defined presenting complaint, and systemic disease was used to match PAHs to OCU acute care visits. PAH costs obtained from OCM data were compared to costs from matched OCU visits. RESULTS: We identified 130 acute care OCU visits, of which 47 met inclusion criteria. Twenty-four PAHs (89%) matched to 26 of these OCU visits. PAHs accounted for 5.8% of OCM expenditures during our study period. The mean inpatient cost among matched PAHs was $15,885 compared to $6,227 for matched OCU visits. Boot strapping within each match stratum produced a mean estimated cost savings of $12,151 (95% CI $10,488 to $13,814) per PAH. We estimate this per event savings to yield a 4.4% (95% CI 3.8% to 5.0%) an overall spending decrement for OCM prostate cancer episodes. CONCLUSIONS: PAHs contribute meaningfully to costs of care in oncology. Investment in specialized ambulatory acute care services for oncology patients could lead to substantial cost savings.
PURPOSE/ OBJECTIVES: We sought to estimate the expected cost savings generated if a set of potentially avoidable hospitalizations (PAHs) among oncology care model (OCM) patients with prostate cancer were shifted to an acute care model in the outpatient setting. METHODS: We previously identified a set of 28 PAHs among OCM prostate cancer patients. Outpatient management costs for a characteristically similar cohort of cancer patients were obtained from our institution's ambulatory acute-care Oncology Care Unit (OCU). We excluded OCU visits resulting in hospitalization, involving non-cancer diagnoses, and those missing clinical/financial information. Exact-matching based on the strata of age, categorically-defined presenting complaint, and systemic disease was used to match PAHs to OCU acute care visits. PAH costs obtained from OCM data were compared to costs from matched OCU visits. RESULTS: We identified 130 acute care OCU visits, of which 47 met inclusion criteria. Twenty-four PAHs (89%) matched to 26 of these OCU visits. PAHs accounted for 5.8% of OCM expenditures during our study period. The mean inpatient cost among matched PAHs was $15,885 compared to $6,227 for matched OCU visits. Boot strapping within each match stratum produced a mean estimated cost savings of $12,151 (95% CI $10,488 to $13,814) per PAH. We estimate this per event savings to yield a 4.4% (95% CI 3.8% to 5.0%) an overall spending decrement for OCM prostate cancer episodes. CONCLUSIONS: PAHs contribute meaningfully to costs of care in oncology. Investment in specialized ambulatory acute care services for oncology patients could lead to substantial cost savings.
Entities:
Keywords:
Acute oncology care; Oncology Care Model; Potentially avoidable hospitalizations; Prostate cancer outcomes; Value-based healthcare
Authors: Anish B Parikh; William Smith; Mark Sanderson; Kavita Dharmarajan; Mark Liu; Luis Isola; Ronald D Ennis Journal: J Oncol Pract Date: 2019-02-11 Impact factor: 3.840
Authors: Gabriel A Brooks; Thomas A Abrams; Jeffrey A Meyerhardt; Peter C Enzinger; Karen Sommer; Carole K Dalby; Hajime Uno; Joseph O Jacobson; Charles S Fuchs; Deborah Schrag Journal: J Clin Oncol Date: 2014-01-13 Impact factor: 44.544
Authors: Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown Journal: J Natl Cancer Inst Date: 2011-01-12 Impact factor: 13.506
Authors: K Robin Yabroff; Elizabeth B Lamont; Angela Mariotto; Joan L Warren; Marie Topor; Angela Meekins; Martin L Brown Journal: J Natl Cancer Inst Date: 2008-04-29 Impact factor: 13.506
Authors: Areej El-Jawahri; Tanya Keenan; Gregory A Abel; David P Steensma; Thomas W LeBlanc; Yi-Bin Chen; Gabriela Hobbs; Lara Traeger; Amir T Fathi; Daniel J DeAngelo; Martha Wadleigh; Karen K Ballen; Philip C Amrein; Richard M Stone; Jennifer S Temel Journal: Lancet Haematol Date: 2016-05-18 Impact factor: 18.959